Star Witness Expected Today At Martoma Trial

Jan 17 2014 | 4:12am ET

The key witness in the insider-trading case against former SAC Capital Advisors portfolio manager Mathew Martoma could take the stand today.

Sidney Gilman, a former medical professor at the University of Michigan, is expected to testify that he gave Martoma confidential information about Alzheimer's drug trials. Martoma is accused of using that information to trade two pharmaceutical shares, earning or saving SAC some $276 million in what prosecutors have called the "most lucrative" insider-trading scheme in history.

Gilman is cooperating with prosecutors. Martoma's lawyers told the jury in their opening statements that the entire case would hinge on Gilman, whom they say is testifying against Martoma to save his own skin.

Gilman's testimony will follow that of another doctor, Joel Ross, who told the jury that he also gave Martoma insider information about the drug trials. Ross also said he was surprised about how much Martoma knew about the trials; prosecutors say he got the information from Gilman.

Two other witnesses took the stand yesterday: SAC compliance officer John Casey and former Elan Corp. scientist Enchi Liu. Casey said that Martoma attended at least two annual compliance sessions held by SAC, in 2007 and 2008, during which he went over insider-trading regulations. Liu, apparently setting the stage for Gilman, testified that the doctor—who served as chairman of the drug trial's safety committee—was bound by confidentiality agreements.


In Depth

Q&A: High Conviction, Low Correlation

Oct 30 2014 | 7:35am ET

Acadian Asset Management's numbers are big: over $70 billion in assets under management...

Lifestyle

Ex-Hedgie Steyer Gives $56M To Climate Action Super PAC

Oct 28 2014 | 9:23am ET

Retired Farallon Capital founder Tom Steyer has poured almost $56 million into his...

Guest Contributor

Hedge Funds Weather A Data Management Perfect Storm

Oct 22 2014 | 12:28pm ET

From a regulatory standpoint, nearly every development since the crisis has placed...

 

Videos

Editor's Note

    Guidelines for Guest Articles

    Oct 22 2014 | 9:46am ET

    We are always looking for guest articles from hedge fund managers and buy-side firms.

    If you are interested in submitting a contributed piece for possible publication on FINalternatives, please take a look at the specs. Read more…

 

Futures Magazine

October 2014 Cover

Demeter: Family affair

David and James Hamman launched their fundamental Livestock and Grains Program in March of 2010 but it really was decades in the making.

The Alpha Pages

TAP July/August 2014 Cover

The Alpha Pages Interview: Senator Rand Paul

Senator Paul sat down in the debut series of the Alpha Pages Interview to discuss the broken tax code, regulation surrounding Bitcoin, and his plans for the 2016 Presidential election.